Carrie Clark
Director of Genspect UK
As Director of Genspect UK, Carrie Clark monitors the institutional machinery behind paediatric gender medicine. When the NHS announced a new puberty blocker trial despite the Cass Review's damning conclusions, she joined Stella O'Malley and Mia Hughes to dissect why that decision should worry Irish parents, clinicians and policymakers just as much as British ones.
Carrie Clark is Director of Genspect UK, the British arm of the international alliance that brings together clinicians, researchers, parents and detransitioners calling for rigorous, evidence-based medicine when children and teenagers are distressed about their gender. Her work focuses on clinical governance, institutional accountability and the quality of evidence that regulatory bodies and health services rely on when making decisions about paediatric medical transition.
In the Beyond Gender episode The UK is Restarting a Puberty Blocker Trial Despite 25 Years of Evidence (episode 4, March 2025), Clark joined hosts Stella O'Malley and Mia Hughes in the immediate aftermath of the NHS England announcement of a new puberty blocker research programme. She made the case that the announcement — coming after the Cass Review had systematically catalogued the paucity of reliable evidence for paediatric medical transition — revealed how deeply the ideological framework underpinning gender-affirmative care remains embedded in health institutions. Twenty-five years of inconclusive or methodologically compromised research, she argued, was being used to justify yet more research rather than a genuine clinical pause and rethink.
For Irish listeners the conversation is not a distant British story. Ireland's paediatric gender services developed alongside and in dialogue with the UK model; the same clinical assumptions, professional networks and advocacy pressures that shaped the Gender Identity Development Service at the Tavistock have influenced how gender-questioning children are assessed by the HSE. The HSE's own review of these services has tracked closely behind the UK reckoning, and Clark's analysis of why institutional reform is harder than it looks illuminates exactly the obstacles Irish healthcare now faces.
Her perspective — systemic, policy-focused and grounded in the experiences of the families Genspect UK supports — makes her one of the more forensic voices explaining why good intentions and poor evidence can coexist inside the same clinical programme, and why a restarted trial that the Cass Review effectively indicted should give pause to parents, GPs, school counsellors and legislators on both sides of the Irish Sea.
